Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Castello

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Clinical Nuclear Medicine|August 18, 2020
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET ExperienceTimothée Zaragori, Angelo Castello, Eric Guedj, et al.
Clinical Lung Cancer|August 15, 2019
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant ChemotherapyAngelo Castello, Luca Toschi, Sabrina Rossi, et al.
BMJ Open|March 30, 2021
Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocolEgesta Lopci, Roberta Burnelli, Caterina Elia, et al.
Nuclear Medicine Communications|April 3, 2018
Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancerAngelo Castello, Fabio Grizzi, Luca Toschi, et al.
Nuclear Medicine Communications|March 16, 2019
Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomographyEgesta Lopci, Angelo Castello, Emanuela Morenghi, et al.
International Journal of Molecular Sciences|November 11, 2022
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic ReviewLuca Urso, Luigi Manco, Angelo Castello, et al.
Journal of Clinical Medicine|December 23, 2023
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-ArtLuigi Manco, Domenico Albano, Luca Urso, et al.
Journal of Clinical Medicine|August 26, 2023
Comparison of MRI vs. [<sup>18</sup>F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future PerspectivesMatteo Caracciolo, Angelo Castello, Luca Urso, et al.
Molecular Diagnosis & Therapy|November 8, 2024
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [<sup>18</sup>F]FDG AlternativesPriscilla Guglielmo, Cinzia Crivellaro, Angelo Castello, et al.
Immunity|June 28, 2011
B cell receptor-mediated antigen gathering requires ubiquitin ligase Cbl and adaptors Grb2 and Dok-3 to recruit dynein to the signaling microclusterTim Schnyder, Angelo Castello, Christoph Feest, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Clinical Nuclear Medicine|August 18, 2020
Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value: A Multicentric 11C-Methionine and 18F-FDOPA PET ExperienceTimothée Zaragori, Angelo Castello, Eric Guedj, et al.
Clinical Lung Cancer|August 15, 2019
Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant ChemotherapyAngelo Castello, Luca Toschi, Sabrina Rossi, et al.
BMJ Open|March 30, 2021
Additional value of volumetric and texture analysis on FDG PET assessment in paediatric Hodgkin lymphoma: an Italian multicentric study protocolEgesta Lopci, Roberta Burnelli, Caterina Elia, et al.
Nuclear Medicine Communications|April 3, 2018
Tumor heterogeneity, hypoxia, and immune markers in surgically resected non-small-cell lung cancerAngelo Castello, Fabio Grizzi, Luca Toschi, et al.
Nuclear Medicine Communications|March 16, 2019
Cost-effectiveness of second-line diagnostic investigations in patients included in the DANTE trial: a randomized controlled trial of lung cancer screening with low-dose computed tomographyEgesta Lopci, Angelo Castello, Emanuela Morenghi, et al.
International Journal of Molecular Sciences|November 11, 2022
PET-Derived Radiomics and Artificial Intelligence in Breast Cancer: A Systematic ReviewLuca Urso, Luigi Manco, Angelo Castello, et al.
Journal of Clinical Medicine|December 23, 2023
Positron Emission Tomography-Derived Radiomics and Artificial Intelligence in Multiple Myeloma: State-of-the-ArtLuigi Manco, Domenico Albano, Luca Urso, et al.
Journal of Clinical Medicine|August 26, 2023
Comparison of MRI vs. [<sup>18</sup>F]FDG PET/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future PerspectivesMatteo Caracciolo, Angelo Castello, Luca Urso, et al.
Molecular Diagnosis & Therapy|November 8, 2024
Emerging Radiopharmaceuticals in Pet Imaging for Mesothelioma: A Review of [<sup>18</sup>F]FDG AlternativesPriscilla Guglielmo, Cinzia Crivellaro, Angelo Castello, et al.
Immunity|June 28, 2011
B cell receptor-mediated antigen gathering requires ubiquitin ligase Cbl and adaptors Grb2 and Dok-3 to recruit dynein to the signaling microclusterTim Schnyder, Angelo Castello, Christoph Feest, et al.
Pageof 8